Cybin Inc.

Cybin Inc

Biotech & Life Sciences

Sector

Seed

Stage

Pharmaceutical development

Model

01Company Overview

Cybin Inc. is a clinical-stage neuropsychiatry company focused on revolutionizing mental healthcare through the development of next-generation treatment options, particularly utilizing psychedelic therapeutics.

02Backed By2 investors

ACAwareness Capital→PbPivotal bioVenture Partners→

Is this your company? Claim your profile

03

Recent Activity

FROM Awareness Capital

Cybin Inc., a portfolio company of Awareness Capital, completed a legal name change to Helus Pharma Inc. effective October 1, 2026, after shareholder approval on September 22, 2026. The company trades under the ticker HELP on NASDAQ and Cboe Canada.